These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22891106)

  • 1. High-resolution CT vascular imaging using blood pool contrast agents.
    Annapragada AV; Hoffman E; Divekar A; Karathanasis E; Ghaghada KB
    Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):18-22. PubMed ID: 22891106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution 3D visualization of nanomedicine distribution in tumors.
    Moss JI; Barjat H; Emmas SA; Strittmatter N; Maynard J; Goodwin RJA; Storm G; Lammers T; Puri S; Ashford MB; Barry ST
    Theranostics; 2020; 10(2):880-897. PubMed ID: 31903157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle contrast agents for computed tomography: a focus on micelles.
    Cormode DP; Naha PC; Fayad ZA
    Contrast Media Mol Imaging; 2014; 9(1):37-52. PubMed ID: 24470293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.
    Ghaghada KB; Badea CT; Karumbaiah L; Fettig N; Bellamkonda RV; Johnson GA; Annapragada A
    Acad Radiol; 2011 Jan; 18(1):20-30. PubMed ID: 21145026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in nanoparticle imaging technology for vascular pathologies.
    Annapragada A
    Annu Rev Med; 2015; 66():177-93. PubMed ID: 25587649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of nanovectors for therapy and imaging of cardiovascular diseases.
    Eniola-Adefeso O; Heslinga MJ; Porter TM
    Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):13-7. PubMed ID: 22891105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice.
    Cai QY; Kim SH; Choi KS; Kim SY; Byun SJ; Kim KW; Park SH; Juhng SK; Yoon KH
    Invest Radiol; 2007 Dec; 42(12):797-806. PubMed ID: 18007151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-ε-caprolactone tungsten oxide nanoparticles as a contrast agent for X-ray computed tomography.
    Jakhmola A; Anton N; Anton H; Messaddeq N; Hallouard F; Klymchenko A; Mely Y; Vandamme TF
    Biomaterials; 2014 Mar; 35(9):2981-6. PubMed ID: 24393266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Proposed Computed Tomography Contrast Agent Using Carboxybetaine Zwitterionic Tantalum Oxide Nanoparticles: Imaging, Biological, and Physicochemical Performance.
    FitzGerald PF; Butts MD; Roberts JC; Colborn RE; Torres AS; Lee BD; Yeh BM; Bonitatibus PJ
    Invest Radiol; 2016 Dec; 51(12):786-796. PubMed ID: 27115702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent.
    Samei E; Saunders RS; Badea CT; Ghaghada KB; Hedlund LW; Qi Y; Yuan H; Bentley RC; Mukundan S
    Int J Nanomedicine; 2009; 4():277-82. PubMed ID: 20011244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomographic imaging within nuclear cardiology.
    J Nucl Cardiol; 2005; 12(1):131-42. PubMed ID: 15682377
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications.
    Liu Y; Ai K; Lu L
    Acc Chem Res; 2012 Oct; 45(10):1817-27. PubMed ID: 22950890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhenium Sulfide Nanoparticles as a Biosafe Spectral CT Contrast Agent for Gastrointestinal Tract Imaging and Tumor Theranostics in Vivo.
    Wang X; Wang J; Pan J; Zhao F; Kan D; Cheng R; Zhang X; Sun SK
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33650-33658. PubMed ID: 31448891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in ytterbium-based contrast agents for in vivo X-ray computed tomography imaging: promises and prospects.
    Liu Y; Liu J; Ai K; Yuan Q; Lu L
    Contrast Media Mol Imaging; 2014; 9(1):26-36. PubMed ID: 24470292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.
    Cole LE; Ross RD; Tilley JM; Vargo-Gogola T; Roeder RK
    Nanomedicine (Lond); 2015 Jan; 10(2):321-41. PubMed ID: 25600973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spiral computed tomography in the diagnosis of pathology of the vascular bed].
    Makarenko VN; Kozlov VV; Gubskaia NV; Obel'chak IS; Ivanitskiĭ AV
    Vestn Rentgenol Radiol; 1996; (5):21-5. PubMed ID: 8967006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of water-soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT.
    Nebuloni L; Kuhn GA; Müller R
    Acad Radiol; 2013 Oct; 20(10):1247-55. PubMed ID: 24029056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiothoracic CT angiography: current contrast medium delivery strategies.
    Weininger M; Barraza JM; Kemper CA; Kalafut JF; Costello P; Schoepf UJ
    AJR Am J Roentgenol; 2011 Mar; 196(3):W260-72. PubMed ID: 21343473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance dendritic contrast agents for X-ray computed tomography imaging using potent tetraiodobenzene derivatives.
    You S; Jung HY; Lee C; Choe YH; Heo JY; Gang GT; Byun SK; Kim WK; Lee CH; Kim DE; Kim YI; Kim Y
    J Control Release; 2016 Mar; 226():258-67. PubMed ID: 26812006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging.
    Criscione JM; Dobrucki LW; Zhuang ZW; Papademetris X; Simons M; Sinusas AJ; Fahmy TM
    Bioconjug Chem; 2011 Sep; 22(9):1784-92. PubMed ID: 21851119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.